Wells Fargo Downgrades West Pharmaceutical (WST) to Market Perform
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Wells Fargo downgraded West Pharmaceutical (NYSE: WST) from Outperform to Market Perform.
Shares of West Pharmaceutical closed at $81.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Blood Therapeutics' (GBT) GBT440 Has Potential for Peak Sales of $2.7B, Says Wells Fargo; Analyst Initiates Coverage at 'Outperform'
- UPDATE: Stifel Downgrades Targa Resources (TRGP) to Hold
- West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesWells Fargo
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!